Results 41 to 50 of about 91,384 (208)

Pneumococcal meningitis in adults in 2014–2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in Japan

Scientific Reports, 2022
We assessed the impact of the pediatric 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal meningitis in adults in Japan in 2014–2018 by comparing epidemiological characteristics of adults with invasive pneumococcal disease with (n = 222 ...
Bin Chang, Kosuke Tamura, Hiroyuki Fujikura, Hiroshi Watanabe, Yoshinari Tanabe, Koji Kuronuma, Jiro Fujita, Kengo Oshima, Takaya Maruyama, Shuichi Abe, Kei Kasahara, Junichiro Nishi, Tetsuya Kubota, Yuki Kinjo, Yusuke Serizawa, Reiko Shimbashi, Munehisa Fukusumi, Tomoe Shimada, Tomimasa Sunagawa, Motoi Suzuki, Kazunori Oishi, the Adult IPD Study Group   +21 more
doaj   +1 more source

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine. [PDF]

, 2012
BACKGROUND: A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected Gambian children against pneumococcal disease and reduced nasopharyngeal carriage of pneumococci of vaccine serotypes.
Greenwood, Brian M, Godwin C. Enwere, Brown J Okoko, Nsekpong, Ekpedeme D, Godwin C Enwere, Ekpedeme D Nsekpong, Syed M. A. Zaman, Aderonke A. Odutola, Saaka, Mark, Zaman, Syed MA, Akinsola, Adebayo K, Richard A. Adegbola, Syed M A Zaman, Adebayo K. Akinsola, Aderonke A Odutola, Richard A Adegbola, Martin O. C. Ota, Okoko, Brown J, Odutola, Aderonke A, Martin O C Ota, Cutts, Felicity T, Felicity T Cutts, Ekpedeme D. Nsekpong, Felicity T. Cutts, Adebayo K Akinsola, Brown J. Okoko, Enwere, Godwin C, Brian M Greenwood, Mark Saaka, Adegbola, Richard A, Brian M. Greenwood, Ota, Martin OC   +31 more
core   +1 more source

A CASE OF PNEUMOCOCCAL MENINGITIS. [PDF]

The Lancet, 1908
n ...
openaire   +1 more source

Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005. [PDF]

, 2008
Introduction of pneumococcal conjugate and polysaccharide vaccines into the United Kingdom's routine immunization programmes is expected to change the epidemiology of invasive pneumococcal disease (IPD).
Dance, DA, Smith, M. D., George, RC, Waight, P., Christensen, H, South West Pneumococcus Study Group, George, R. C., Ihekweazu, Chikwe A., Smith, MD, Stuart, J. M., Dance, DAB, Stuart, JM, SW Pneumococcal Group, Cartwright, KAV, Ihekweazu, CA, Dance, D. A.B., Cartwright, KA, Pebody, R, Christensen, H., Pebody, R., Waight, P, Fletcher, Margaret   +21 more
core   +1 more source

Serotype Distribution and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae in COVID-19 Pandemic Era in Brazil

Microorganisms
Despite the introduction of the pneumococcal vaccine, Streptococcus pneumoniae remains a cause of invasive diseases in Brazil. This study provides the distribution of serotypes and antimicrobial susceptibility patterns for pneumococcal isolates before ...
Samanta C. G. Almeida, Ana Paula S. de Lemos, Ana Luiza Bierrenbach, José Cássio de Moraes, Maria Cristina de Cunto Brandileone   +4 more
doaj   +1 more source

Disease Burden of Meningitis Caused by Streptococcus pneumoniae Among Under-Fives in China: A Systematic Review and Meta-analysis

Infectious Diseases and Therapy, 2023
Introduction Streptococcus pneumoniae is the leading cause of meningitis, with a case fatality of up to about 50%. Children younger than 5 years are at greater risk for pneumococcal meningitis compared with other populations.
Biying Wang, Wanjing Lin, Chen Qian, Youyi Zhang, Genming Zhao, Weibing Wang, Tao Zhang   +6 more
doaj   +1 more source

Genome analysis of a highly virulent serotype 1 strain of streptococcus pneumoniae from West Africa [PDF]

, 2012
Streptococcus pneumoniae is a leading cause of pneumonia, meningitis, and bacteremia, estimated to cause 2 million deaths annually. The majority of pneumococcal mortality occurs in developing countries, with serotype 1 a leading cause in these areas.
Loman Nicholas J., Martin Antonio, Nicholas J Loman, Tiffany M. Williams (126277), Richard A. Adegbola (20657), Pallen, Mark J., Tiffany M. Williams, Weinstock, George M, Mark J. Pallen, Williams, Tiffany M., Loman, Nicholas J., Weinstock, George M., Martin Antonio (42317), Musher, Daniel M., George M. Weinstock, Musher Daniel M., Richard A. Adegbola, Adegbola, Richard A., Richard A Adegbola, Mark J Pallen, George M Weinstock, Daniel M. Musher, Loman, Nicholas J, Nicholas J. Loman (126279), Ebruke Chinelo, Pallen, Mark J, Weinstock George M., Tiffany M Williams, Antonio Martin, Williams, Tiffany M, Ebruke, Chinelo, Daniel M Musher, Mark J. Pallen (8904), Williams Tiffany M., Adegbola Richard A., Pallen Mark J., George M. Weinstock (43281), Daniel M. Musher (126285), Adegbola, Richard A, Chinelo Ebruke (126282), Musher, Daniel M, Antonio, Martin, Nicholas J. Loman, Chinelo Ebruke   +43 more
core   +1 more source

Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.

PLoS ONE, 2021
BackgroundThe 13-valent pneumococcal conjugate vaccine (PCV13) entered Cameroon's childhood national immunization programme (NIP) in July 2011 under a 3-dose schedule (6, 10, 14 weeks of age) without any catch-up.
John Njuma Libwea, Mark A Fletcher, Paul Koki Ndombo, Angeline Boula, Nadesh Taku Ashukem, Madeleine Ngo Baleba, Rachel Sandrine Kingue Bebey, Eric Gaston Nkolo Mviena, Jean Tageube, Marie Kobela Mbollo, Sinata Koulla-Shiro, Shabir Madhi, Berthe-Marie Njanpop-Lafourcade, Ali Mohammad, Elizabeth Begier, Joanna Southern, Rohini Beavon, Bradford Gessner   +17 more
doaj   +1 more source

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. [PDF]

, 2010
BACKGROUND: The presentation and causes of adult meningitis in South Africa have changed substantially as a result of HIV. Knowledge of aetiology and laboratory findings in patients presenting with meningitis are important in guiding management.
Crede Tom, Williams, A, Thomas S Harrison, Meintjes, Graeme, Brown Yolande, Harrison Thomas S, Jarvis, Joseph, Yolande Brown, Tom Crede, Joseph N Jarvis, Jarvis, JN, Meintjes Graeme, Harrison, Thomas, Crede, Tom, Anthony Williams, Jarvis Joseph N, Harrison, Thomas S, Brown, Y, Brown, Yolande, Harrison, TS, Crede, T, Williams, Anthony, Graeme Meintjes, Williams Anthony, Meintjes, G, Jarvis, Joseph N   +25 more
core   +2 more sources

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

, 2010
In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance.
Perrocheau, Anne, Celentano, Lucia Pastore, Stuart, James, de Greeffk, Sabine C, Kissling E, Lévy-Bruhl, Daniel, ECDC Country Experts for Pneumococcal Disease, Celentano LP, de Greeff, Sabine C, Tarragó, David, Stefanoff P, Amato-Gauci A, Kriz, Paula, Heuberger, Sigrid, Amato-Gauci, Andrew, Bruhl DL, Tarragó D, de Greef SC, Kriz P, Hanquet G, Kissling, Esther, ECDC country experts for pneumococcal disease, incl., Vergison A, Hanquet, Germaine, Stefanoff, Pawel, Heuberger S, Vergison, Anne, Bruhl, Daniel Levy, Perrocheau A, de Greeff, Sabine C., Stuart J, Mühlemann, Kathrin   +31 more
core   +1 more source